For an optimal experience please
rotate your device to portrait mode
G42 and Mubadala to establish a biopharma manufacturing campus
G42, the leading UAE-based AI and cloud computing company, and Mubadala Investment Company PJSC (Mubadala) signed an agr...
December 23, 2021
G42 Healthcare, AstraZeneca to collaborate on clinical research and diagnostics
G42 Healthcare and AstraZeneca to collaborate on clinical research and diagnostics.
December 22, 2021
G42 Healthcare to offer lab on wheels
G42 Healthcare, Seegene MoU to offer molecular diagnostic testing laboratory-on-wheels in MENA
June 21, 2021
G42 Healthcare collaborates to develop Abu Dhabi wastewater monitoring lab
The Wastewater Monitoring Lab aims to enhance systems for the early detection of threats to public health.
June 21, 2021
G42 Healthcare to showcase leading solutions at Arab Health 2021
G42 Healthcare, a leading health-tech company on a mission to develop a world-class healthcare sector in the UAE and bey...
June 20, 2021
Emirati Genome Program adds sample collection centers
Emiratis of all ages are encouraged to participate in the Emirati Genome Program, which aims to better predict and preve...
May 4, 2021
G42 Healthcare and GenScript announce collaboration to provide innovative solutions to fight against...
G42 Healthcare, a leading healthcare technology company, based in the UAE and GenScript Biotech Singapore, a subsidiary ...
March 18, 2021
G42 Healthcare and UAEU sign MoU for collaboration on research projects
Zaki Nusseibeh, Cultural Advisor to the UAE President, Chancellor of the United Arab Emirates University (UAEU), recentl...
March 2, 2021
G42 Healthcare and Khalifa University Sign MoU on Research Collaboration
Khalifa University of Science and Technology and G42 Healthcare, a subsidiary of the Abu Dhabi-based technology company ...
February 22, 2021
G42 Healthcare signs agreement with Rafed for management and storage of COVID-19 vaccines
As part of the agreement, Rafed will oversee the management, transportation, and storage of the vaccine doses in the new...
February 19, 2021
G42 Healthcare inaugurates Omics Centre of Excellence
G42 Healthcare, a subsidiary of Abu Dhabi-based technology company Group 42 (G42), held an official inauguration ceremon...
January 25, 2021
G42 Healthcare identifies genomic source of COVID-19 pandemic
G42 Healthcare has conducted a SARS-CoV-2 genome sequencing study that has identified the genomic source of the COVID-19...
January 7, 2021
Biogenix Labs collaborates with ADQCC to provide Proficiency Testing for COVID-19 PCR
Biogenix Labs, a G42 Healthcare company, in collaboration with the Abu Dhabi Quality and Conformity Council (ADQCC), has...
October 25, 2020
G42 Healthcare COVID-19 vaccine trials expand to Egypt
As part of the ongoing efforts to expand the reach of the Phase III clinical trials of an inactivated COVID-19 vaccine, ...
September 17, 2020
Detecting COVID-19 From Scent: G42 Healthcare And NanoScent To Collaborate On Breakthrough Solution
A non-invasive, easy to use, portable nasal scent reader will enable COVID-19 detection in 30 to 60 seconds.
August 19, 2020
4Humanity Covid-19 vaccine Clinical Trials expand to Bahrain
Abu Dhabi-based G42 Healthcare has extended the world’s first Phase III trials of an inactivated COVID-19 vaccine to a...
August 12, 2020
World’s First Phase III Clinical Trial of COVID-19 Inactivated Vaccine Begins in UAE
The first WHO enlisted global clinical Phase III trial of Sinopharm CNBG’s inactivated vaccine to combat COVID-19 has ...
July 16, 2020
G42 joins forces with Israeli Rafael and IAI to defeat Covid-19
The companies will explore joint research and development programs to develop groundbreaking solutions against the coron...
July 3, 2020
G42 and Sinopharm launch world’s first phase III clinical trial of Covid-19 vaccine
Following a ceremony held today via video conference between Abu Dhabi and Beijing, health authorities from the United A...
June 24, 2020
G42 and ONT Co-Develop Ultra-Scalable Solution for COVID-19 Detection
The end-to-end solution will enable screening in mass and on demand to support the re-opening of global economies.
June 9, 2020
G42 Healthcare Launches Health AI Services to Accelerate COVID-19 Diagnosis and Drug Discovery
The AI-powered, cloud-based solution, provides researchers, medical organizations and scientific institutes across the w...
May 19, 2020
G42 and BGI Announce COVID-19 Detection Lab
G42 and BGI announced today the launch of a new massive-throughput laboratory built to address the need for population-s...
March 31, 2020
Group 42 Helps China Combat Coronavirus outbreak
The Abu Dhabi based technological powerhouse takes the field in defense of populations threatened by the deadly Coronavi...
January 29, 2020
DoH and G42 announce Genome Program
The Department of Health – Abu Dhabi announced today the launch of the Genome Program, a national project set to use l...
December 10, 2019